THRD logo

Third Harmonic Bio (THRD) EBITDA

Annual EBITDA

-$65.52 M
+$205.29 M+75.81%

December 31, 2023


Summary


Performance

THRD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTHRDprofitabilitymetrics:

Quarterly EBITDA

-$17.06 M
-$3.00 M-21.36%

September 30, 2024


Summary


Performance

THRD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTHRDprofitabilitymetrics:

TTM EBITDA

-$52.79 M
-$6.23 M-13.37%

September 30, 2024


Summary


Performance

THRD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTHRDprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

THRD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+75.8%-57.5%-12.1%
3 y3 years-142.0%-25.9%-40.0%
5 y5 years+3.7%-25.9%-40.0%

THRD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-178.4%+75.8%-196.7%at low-361.1%at low
5 y5-year-142.0%+75.8%-199.5%at low-826.6%at low
alltimeall time-142.0%+75.8%-199.5%at low-826.6%at low

Third Harmonic Bio EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$17.06 M(+21.4%)
-$52.79 M(+13.4%)
Jun 2024
-
-$14.06 M(+24.6%)
-$46.56 M(+7.8%)
Mar 2024
-
-$11.28 M(+8.5%)
-$43.21 M(-1.6%)
Dec 2023
-$65.52 M(-75.8%)
-$10.39 M(-4.1%)
-$43.92 M(-6.7%)
Sep 2023
-
-$10.84 M(+1.2%)
-$47.08 M(+5.0%)
Jun 2023
-
-$10.71 M(-10.7%)
-$44.83 M(+7.0%)
Mar 2023
-
-$11.98 M(-11.5%)
-$41.91 M(+11.1%)
Dec 2022
-$270.81 M
-$13.55 M(+57.8%)
-$37.71 M(+26.1%)
Sep 2022
-
-$8.59 M(+10.3%)
-$29.91 M(+10.7%)
Jun 2022
-
-$7.78 M(-0.1%)
-$27.02 M(+40.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$7.79 M(+35.4%)
-$19.23 M(+68.0%)
Dec 2021
$83.57 M(-46.4%)
-
-
Dec 2021
-
-$5.75 M(+0.9%)
-$11.45 M(+100.9%)
Sep 2021
-
-$5.70 M
-$5.70 M
Dec 2020
$155.98 M(-182.2%)
-
-
Dec 2019
-$189.64 M(+178.7%)
-
-
Dec 2018
-$68.03 M(-59.2%)
-
-
Dec 2017
-$166.85 M(-647.8%)
-
-
Dec 2016
$30.46 M(-134.9%)
-
-
Dec 2015
-$87.33 M(-39.3%)
-
-
Dec 2014
-$143.84 M
-
-

FAQ

  • What is Third Harmonic Bio annual EBITDA?
  • What is the all time high annual EBITDA for Third Harmonic Bio?
  • What is Third Harmonic Bio annual EBITDA year-on-year change?
  • What is Third Harmonic Bio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Third Harmonic Bio?
  • What is Third Harmonic Bio quarterly EBITDA year-on-year change?
  • What is Third Harmonic Bio TTM EBITDA?
  • What is the all time high TTM EBITDA for Third Harmonic Bio?
  • What is Third Harmonic Bio TTM EBITDA year-on-year change?

What is Third Harmonic Bio annual EBITDA?

The current annual EBITDA of THRD is -$65.52 M

What is the all time high annual EBITDA for Third Harmonic Bio?

Third Harmonic Bio all-time high annual EBITDA is $155.98 M

What is Third Harmonic Bio annual EBITDA year-on-year change?

Over the past year, THRD annual EBITDA has changed by +$205.29 M (+75.81%)

What is Third Harmonic Bio quarterly EBITDA?

The current quarterly EBITDA of THRD is -$17.06 M

What is the all time high quarterly EBITDA for Third Harmonic Bio?

Third Harmonic Bio all-time high quarterly EBITDA is -$5.70 M

What is Third Harmonic Bio quarterly EBITDA year-on-year change?

Over the past year, THRD quarterly EBITDA has changed by -$6.23 M (-57.46%)

What is Third Harmonic Bio TTM EBITDA?

The current TTM EBITDA of THRD is -$52.79 M

What is the all time high TTM EBITDA for Third Harmonic Bio?

Third Harmonic Bio all-time high TTM EBITDA is -$5.70 M

What is Third Harmonic Bio TTM EBITDA year-on-year change?

Over the past year, THRD TTM EBITDA has changed by -$5.71 M (-12.14%)